Henry Schein Stock

Henry Schein EBITDA per Employee

The EBITDA per Employee of Henry Schein (HSIC) as of Aug 18, 2026 is 55,315.79 USD. In the previous year, EBITDA per Employee was 53,105.26 USD — a change of 4.16% (higher).

EBITDA per Employee

55,315.79USD

YoY

4.16%

Last updated:

EBITDA per Employee of Henry Schein is 2026 55,315.79 USD. EBITDA per Employee of Henry Schein was 2025 53,105.26 USD. It decreases by 4.16% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

Henry Schein Stock analysis

What does Henry Schein do? Henry Schein Inc is a global provider of medical products and services for the healthcare industry based in Melville, New York. It was founded in 1932 by Henry Schein and has a long history of providing high-quality products and services for the healthcare industry. The company specializes in four core areas: medical products, services, medical software, and veterinary products. In the medical products area, Henry Schein distributes a wide range of medical products and equipment, including dental and orthodontic products, surgical instruments and supplies, medical laboratory equipment and supplies, and furnishings for practices. The company strives to offer its customers the best selection of medical products at a competitive price. Henry Schein also offers services aimed at making the work of healthcare providers easier. For example, the company provides services such as practice management software, online pharmacies, insurance, and billing services to optimize the operation of a medical or veterinary practice. Another important area of the company is medical software. Henry Schein offers an extensive range of software solutions for medical and veterinary practices, as well as hospitals and other medical facilities. The software facilitates tasks such as electronic medical records, appointment scheduling, and financial management, enabling practices and hospitals to operate more efficiently. Henry Schein has also specialized in the field of veterinary medicine, offering a wide range of products and services for veterinarians and animal clinics. The company distributes veterinary instruments, laboratory equipment, surgical instruments, and veterinary medications, and also provides services such as practice management software and veterinary billing. The company aims to provide its customers with a comprehensive range of products and services in a variety of areas. Henry Schein has established itself as an industry leader and is valued for its high quality and excellent customer service. Henry Schein is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Henry Schein stock

EBITDA per Employee of Henry Schein is 55,315.79 USD in 2026.

EBITDA per Employee of Henry Schein changed from 53,105.26 USD to 55,315.79 USD, representing a 4.16% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Henry Schein since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Henry Schein historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — Henry Schein

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Henry Schein